OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 1 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,920 | -18.8% | 2,000 | -42.9% | 0.01% | -25.0% |
| Q3 2023 | $10,990 | -39.1% | 3,500 | 0.0% | 0.01% | -38.5% |
| Q2 2023 | $18,060 | +100233.3% | 3,500 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $18 | +157.1% | 3,500 | +40.0% | 0.01% | +180.0% |
| Q4 2022 | $7 | -99.9% | 2,500 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $10,000 | 0.0% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $10,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |